TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneum...(obal Business Development Tel: +88...),Health
TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
obal Business Development ... Tel: +886-2-2790-1861 ... Fax: +8862-2790-9962 ... Email: sip@taigenbiotech.com/... Add: 7F 138 Shin Ming Rd. Neihu Dist. Taipei Taiwan 11470 R.O.C....